The biochemical aftermath of anti-amyloid immunotherapy

BACKGROUND: Active and passive immunotherapy in both amyloid-beta precursor protein (APP) transgenic mice and Alzheimer's Disease (AD) patients have resulted in remarkable reductions in amyloid plaque accumulation, although the degree of amyloid regression has been highly variable. Nine individ...

Descripción completa

Detalles Bibliográficos
Autores principales: Maarouf, Chera L, Daugs, Ian D, Kokjohn, Tyler A, Kalback, Walter M, Patton, R Lyle, Luehrs, Dean C, Masliah, Eliezer, Nicoll, James AR, Sabbagh, Marwan N, Beach, Thomas G, Castaño, Eduardo M, Roher, Alex E
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2959013/
https://www.ncbi.nlm.nih.gov/pubmed/20929585
http://dx.doi.org/10.1186/1750-1326-5-39

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2959013/
https://www.ncbi.nlm.nih.gov/pubmed/20929585
http://dx.doi.org/10.1186/1750-1326-5-39

Ejemplares similares